Advanced Silicon Group ends the issuance of preferred shares and adds Alan Watson and Sarah Kelly to the board of directors

[ad_1]

Advanced Silicon Group, Inc. (ASG), a pioneer in silicon nanotechnology focusing on the development of new biosensors, today announced the completion of a $1,020,000 seed preferred stock offering led by Cherrystone Angel Group, Northern California’s MIT Alumni Angels, Sidecar Angels and other private investments And added two new directors to its board of directors, Dr. Alan Watson of MBA and Dr. Sarah Kelly.

Lowell, Massachusetts, May 16, 2021-(PR.com)-Advanced Silicon Group, Inc. (ASG), a pioneer in silicon nanotechnology focusing on the development of new biosensors, announced today that the issuance of US$1,020,000 seed preferred shares led by Cherrystone Angel Group has been completed. MIT alumni from Northern California, Angels, participated in the event. Issuance, Sidecar Angels and other private investors.

Dr. Marcie Black, CEO of ASG, said: “We are very pleased to achieve this important financing milestone and are satisfied that investors are very interested in ASG’s proprietary silicon-based biosensor technology.” “We We are now ready to advance our plan to complete the development of our first biosensor product. The goal is to implement a new method of in-process ELISA testing in the biopharmaceutical industry and begin initial testing with commercial customers.”

As part of the financing, ASG appointed two new directors to the board of directors, Dr. Alan Watson and Dr. Sarah Kelly. Dr. Black said: “Alan and Sarah both have extensive experience in the biopharmaceutical industry, and we look forward to them becoming part of our team.”

About Advanced Silicon Group, Inc.

Advanced Silicon Group, Inc., located in Lowell, Massachusetts, is a company dedicated to the development and commercialization of new biosensors based on its patented silicon nanowire technology. ASG owns patents and exclusive licenses for the core technology of manufacturing cheap nanostructures on silicon and its wide application in various biomedical fields.

contact:
Bill Rever
Co-founder and Chief Marketing and Sales Officer
Bill.rever@advancedsilicongroup.com
www.advancedsilicongroup.com

Contact information:
Advanced Silicon Group
Bill Rever
301-502-3775
Contact by email
www.advancedsilicongroup.com

Read the full text here: https://www.pr.com/press-release/836599

Press release issued by PR.com

[ad_2]

Source link